CIK 0001497253
- Non-accelerated filer
- Smaller reporting company
VivoSim Labs, INC.
Sign in to watch- Ticker
- VIVS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 271488943
- Phone
- +1 858-224-1000
- Business address
- 11555 SORRENTO VALLEY ROAD, SUITE 100, SAN DIEGO, CA, 92121
- Former names
- ORGANOVO HOLDINGS, INC., REAL ESTATE RESTORATION & RENTAL, INC.
- Open-market buys, last 90 days
- $2,804
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$2,804. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-11-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −5,625 | $1.47 | $8K | 876,609 |
| 2017-08-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −8,469 | $2.06 | $17K | 882,234 |
| 2017-06-27 | David Eric CSO & EVP Pre-Clinical Dev | Grant or award | +190,000 | 890,703 | ||
| 2017-05-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,263 | $2.86 | $4K | 700,703 |
| 2017-02-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,390 | $2.95 | $4K | 701,966 |
| 2016-11-16 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,745 | $3.26 | $6K | 703,356 |
| 2016-08-19 | David Eric CSO & EVP Pre-Clinical Dev | Shares withheld for taxes | −1,205 | $4.00 | $5K | 705,101 |
| 2016-08-05 | David Eric CSO & EVP Pre-Clinical Dev | Sale | −20,000 | $4.55 | $91K | 706,306 |
| 2016-07-11 | David Eric CSO & EVP Pre-Clinical Dev | Grant or award | +50,000 | 726,306 | ||
| 2016-07-11 | David Eric CSO & EVP Pre-Clinical Dev | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2015-06-04 | David Eric CSO & EVP Pre-Clinical Dev | Grant or award · Stock Option (Rignt to Buy) | +130,000 | 130,000 | ||
| 2014-12-30 | David Eric Chief Strategy Officer | Sale | −16,300 | $7.56 | $123K | 681,306 |
| 2014-12-29 | David Eric Chief Strategy Officer | Sale | −3,700 | $7.50 | $28K | 697,706 |
| 2014-09-12 | David Eric Chief Strategy Officer | Sale | −30,000 | $7.30 | $219K | 701,306 |
Page 1 of 1 · 14 trades